160 related articles for article (PubMed ID: 20634801)
1. 8q24 allelic imbalance and MYC gene copy number in primary prostate cancer.
Chen H; Liu W; Roberts W; Hooker S; Fedor H; DeMarzo A; Isaacs W; Kittles RA
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):238-43. PubMed ID: 20634801
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
Sato K; Qian J; Slezak JM; Lieber MM; Bostwick DG; Bergstralh EJ; Jenkins RB
J Natl Cancer Inst; 1999 Sep; 91(18):1574-80. PubMed ID: 10491435
[TBL] [Abstract][Full Text] [Related]
4. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
7. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
[TBL] [Abstract][Full Text] [Related]
8. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Qian J; Jenkins RB; Bostwick DG
Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
[TBL] [Abstract][Full Text] [Related]
9. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma].
Zeng X; Wu SF; Xu Q; Xiao Y; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):523-8. PubMed ID: 17134545
[TBL] [Abstract][Full Text] [Related]
11. Allelic imbalance at an 8q24 oncogenic SNP is involved in activating MYC in human colorectal cancer.
Sugimachi K; Niida A; Yamamoto K; Shimamura T; Imoto S; Iinuma H; Shinden Y; Eguchi H; Sudo T; Watanabe M; Tanaka J; Kudo S; Hase K; Kusunoki M; Yamada K; Shimada Y; Sugihara K; Maehara Y; Miyano S; Mori M; Mimori K
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S515-21. PubMed ID: 24390711
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
13. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
14. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
[TBL] [Abstract][Full Text] [Related]
15. Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance.
Zhou W; Goodman M; Lyles RH; Lim SD; Williams TY; Rusthoven KE; Mandel JS; Amin MB; Petros JA
Prostate; 2004 Sep; 61(1):81-91. PubMed ID: 15287096
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
Troutman SM; Sissung TM; Cropp CD; Venzon DJ; Spencer SD; Adesunloye BA; Huang X; Karzai FH; Price DK; Figg WD
Oncologist; 2012; 17(3):312-20. PubMed ID: 22382457
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
Penney KL; Salinas CA; Pomerantz M; Schumacher FR; Beckwith CA; Lee GS; Oh WK; Sartor O; Ostrander EA; Kurth T; Ma J; Mucci L; Stanford JL; Kantoff PW; Hunter DJ; Stampfer MJ; Freedman ML
Clin Cancer Res; 2009 May; 15(9):3223-30. PubMed ID: 19366828
[TBL] [Abstract][Full Text] [Related]
18. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
Dvorácková J; Uvírová M
Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
[TBL] [Abstract][Full Text] [Related]
19. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
20. Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.
Zhao J; Wu XY; Ling XH; Lin ZY; Fu X; Deng YH; He HC; Zhong W
Med Oncol; 2013 Mar; 30(1):465. PubMed ID: 23377984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
